Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-11-000105
Filing Date
2011-02-14
Accepted
2011-02-14 17:42:43
Documents
1
Group Members
LEE S. AINSLIE IIIMAVERICK CAPITAL MANAGEMENT, LLCMAVERICK CAPITAL, LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A ss111206_sc13ga-cypress.txt SC 13G/A 18516
  Complete submission text file 0000947871-11-000105.txt   20665
Mailing Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121
Business Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121 8584522323
CYPRESS BIOSCIENCE INC (Subject) CIK: 0000716054 (see all company filings)

EIN.: 222389839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-35589 | Film No.: 11608146
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 CRESCENT COURT 18TH FLOOR DALLAS TX 75201
Business Address 300 CRESCENT COURT 18TH FLOOR DALLAS TX 75201 214.880.4050
MAVERICK CAPITAL LTD (Filed by) CIK: 0000934639 (see all company filings)

EIN.: 000000000
Type: SC 13G/A